Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587439 · ClinicalTrials.gov registry record
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
A clinical trial of Lung Cancer and Genetic Disease, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- 500
- Enrollment target
- 2
- Study locations
NCT05587439 is a study of Lung Cancer and Genetic Disease that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 500 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (47% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05587439, a study of Lung Cancer and Genetic Disease, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to learn more about the inherited risk for developing lung cancer.
Conditions Studied
Interventions
- GENETIC Data and Specimen Collection
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2027-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05587439
The ClinicalTrials.gov registry entry for NCT05587439 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (47% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Data and Specimen Collection is the first listed.
NCT05587439 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05587439 about?
NCT05587439 is a clinical study titled "Investigating Hereditary Risk In Thoracic Cancers (INHERIT)". The purpose of this research study is to learn more about the inherited risk for developing lung cancer.
What is the current status of trial NCT05587439?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-01-01. Estimated completion is 2027-11-01.
What conditions does trial NCT05587439 study?
This clinical trial studies the following conditions: Lung Cancer, Genetic Disease, Genetic Predisposition, Hereditary Diseases.
What interventions are being tested in trial NCT05587439?
The interventions under investigation include: Data and Specimen Collection (GENETIC).
Who is sponsoring clinical trial NCT05587439?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05587439 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.